A Randomized, Placebo-controlled, Double-blind Phase 2 Study With OSI-906 in Patients With Advanced HCC
Clinical trial NCT01101906 · TERMINATED
Trial details
- NCT number
- NCT01101906
- Sponsor
- Astellas Pharma Inc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-10
- Primary completion
- 2011-11-04
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.